Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | MEN2501 |
| Synonyms | |
| Therapy Description |
Limited information is currently available on MEN2501, a putative KIF18A inhibitor (Nov 2025). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| MEN2501 | MEN-2501|MEN 2501 | Limited information is currently available on MEN2501, a putative KIF18A inhibitor (Nov 2025). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT07226427 | Phase I | MEN2501 | A First-in-Human Study of MEN2501 in Participants With Platinum-Resistant Ovarian Cancer | Recruiting | USA | 0 |